Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is […]
Source
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in […]
Source
This chart shows the pharmaceutical companies with the most patents in South Africa. Patents must be filed in each country […]
Source
Which pharmaceutical companies have the most drug patents in South Africa? Read Post »
Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection […]
Source
Pharmaceutical companies with the most orphan drugs Read Post »
Patent examiners play a vital role in the patent approval process, particularly in the pharmaceutical industry. Their meticulous examination of patent applications ensures that only valid and innovative patents are granted, thereby safeguarding the pub…
Chiral switching, the practice of developing a single enantiomer from a previously approved racemic drug, has been a significant strategy […]
Source
Is Chiral Switching Still Relevant in Today’s Pricing Control Scenario? Read Post »
Annual Drug Patent Expirations for ABILIFY+ASIMTUFII Abilify Asimtufii is a drug marketed by Otsuka and is included in one NDA. […]
Source
Get new actionable insights and updates from BiotechBlog
